Endocrinology, Vol 137, 3228-3233, Copyright © 1996 by Endocrine Society

ARTICLES

Isoform-specific 3,5,3'-triiodothyronine receptor binding capacity and messenger ribonucleic acid content in rat adenohypophysis: effect of thyroidal state and comparison with extrapituitary tissues

S Ercan-Fang, HL Schwartz and JH Oppenheimer
Department of Medicine, University of Minnesota, Minneapolis 55455, USA.

Although the role of the three functional thyroid hormone receptor isoforms (TR beta 1, TR beta 2, and TR alpha 1) remains unclear, studies by Hodin and Lazar et al. have suggested that restriction of TR beta 2 messenger RNA (mRNA) to rat pituitary could reflect a specific regulatory role in the pituitary. Supporting their hypothesis was a significant fall in pituitary TR beta 2 mRNA after T3 administration. These observations prompted us to assess the effect of thyroidal state on the level of TR beta 2 protein, as inferred by immunoprecipitation of TR beta 2 nuclear binding activity. In contrast to the behavior of the mRNA, we noted surprising stability in the levels of total nuclear TR binding capacity and TR isoform distribution in the transition from hypo- to hyperthyroid states. Calculations based on these and previous data from this laboratory (7) show that the average cellular content of TR beta 2 mRNA in pituitary is 0.6 molecules, whereas the content of TR beta 2 mRNA molecules in extrapituitary tissues is less than 0.007 molecule/cell. A high TR beta 2 protein/mRNA ratio in extrapituitary tissues thus could reflect a rapid turnover of TR beta 2 mRNA compared to TR beta 2 protein. This would explain the widespread distribution of TR beta 2 protein and the scarcity of mRNA in extrapituitary tissues.

This article has been cited by other articles:

				R. Keijzer, P.-J. E Blommaart, W. T Labruyere, J. L M Vermeulen, B. Z. Doulabi, O. Bakker, D. Tibboel, and W. H Lamers Expression of thyroid hormone receptors A and B in developing rat tissues; evidence for extensive posttranscriptional regulation J. Mol. Endocrinol., May 1, 2007; 38(5): 523 - 535. [Abstract] [Full Text] [PDF]

				C. Venero, A. Guadano-Ferraz, A. I. Herrero, K. Nordstrom, J. Manzano, G. M. de Escobar, J. Bernal, and B. Vennstrom Anxiety, memory impairment, and locomotor dysfunction caused by a mutant thyroid hormone receptor {alpha}1 can be ameliorated by T3 treatment Genes & Dev., September 15, 2005; 19(18): 2152 - 2163. [Abstract] [Full Text] [PDF]

				B. Morte, J. Manzano, T. S. Scanlan, B. Vennstrom, and J. Bernal Aberrant Maturation of Astrocytes in Thyroid Hormone Receptor {alpha}1 Knockout Mice Reveals an Interplay between Thyroid Hormone Receptor Isoforms Endocrinology, March 1, 2004; 145(3): 1386 - 1391. [Abstract] [Full Text] [PDF]

				B. Z. Doulabi, M. P.-T. Schiphorst, A. Kalsbeek, E. Fliers, O. Bakker, and W. M. Wiersinga Diurnal Variation in Rat Liver Thyroid Hormone Receptor (TR)-{alpha} Messenger Ribonucleic Acid (mRNA) Is Dependent on the Biological Clock in the Suprachiasmatic Nucleus, whereas Diurnal Variation of TR{beta}1 mRNA Is Modified by Food Intake Endocrinology, March 1, 2004; 145(3): 1284 - 1289. [Abstract] [Full Text] [PDF]

				J. Manzano, B. Morte, T. S. Scanlan, and J. Bernal Differential Effects of Triiodothyronine and the Thyroid Hormone Receptor {beta}-Specific Agonist GC-1 on Thyroid Hormone Target Genes in the Brain Endocrinology, December 1, 2003; 144(12): 5480 - 5487. [Abstract] [Full Text] [PDF]

				B. Morte, J. Manzano, T. Scanlan, B. Vennstrom, and J. Bernal Deletion of the thyroid hormone receptor alpha 1 prevents the structural alterations of the cerebellum induced by hypothyroidism PNAS, March 19, 2002; 99(6): 3985 - 3989. [Abstract] [Full Text] [PDF]

				P. WHITE, K. A. BURTON, A. L. FOWDEN, and M. J. DAUNCEY Developmental expression analysis of thyroid hormone receptor isoforms reveals new insights into their essential functions in cardiac and skeletal muscles FASEB J, June 1, 2001; 15(8): 1367 - 1376. [Abstract] [Full Text] [PDF]

				K. Kinugawa, W. A. Minobe, W. M. Wood, E. C. Ridgway, J. D. Baxter, R. C. J. Ribeiro, M. F. Tawadrous, B. A. Lowes, C. S. Long, and M. R. Bristow Signaling Pathways Responsible for Fetal Gene Induction in the Failing Human Heart : Evidence for Altered Thyroid Hormone Receptor Gene Expression Circulation, February 27, 2001; 103(8): 1089 - 1094. [Abstract] [Full Text] [PDF]

				R. J. Clifton-Bligh, F. de Zegher, R. L. Wagner, T. N. Collingwood, I. Francois, M. Van Helvoirt, R. J. Fletterick, and V. K. K. Chatterjee A Novel TR{beta} Mutation (R383H) in Resistance to Thyroid Hormone Syndrome Predominantly Impairs Corepressor Release and Negative Transcriptional Regulation Mol. Endocrinol., May 1, 1998; 12(5): 609 - 621. [Abstract] [Full Text]

				J. H. Oppenheimer and H. L. Schwartz Molecular Basis of Thyroid Hormone-Dependent Brain Development Endocr. Rev., August 1, 1997; 18(4): 462 - 475. [Abstract] [Full Text] [PDF]